This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Dr. Aude Segaliny, PhD
Senior Director, Head of Research & Early Development at Amberstone Biosciences
Speaker

Profile

Dr. Aude Segaliny, founding scientist and Vice President of Research & Development at Amberstone Biosciences, pioneers next-generation therapeutics with enhanced precision and a markedly improved therapeutic window. Her work is dedicated to advancing safer, more potent treatment options for patients that surpass current standards of care.

Agenda Sessions

  • Redefining TCEs for Solid Tumors: Precision Safety, Efficacy Unlocked

    14:45